Geordan Pursglove

Chairman of the Board of Directors, President and Chief Executive Officer

Mr Pursglove , is an accomplished executive and entrepreneur with more than a decade of experience spanning mergers and acquisitions, public and private capital markets, strategic growth initiatives, and operational leadership. Throughout his career, he has worked across a diverse range of industries, including technology, logistics, customer experience, sports, and marketing, successfully leading organizations through periods of growth, transformation, and value creation. He has built a strong reputation for identifying emerging opportunities, executing complex transactions, and developing scalable business platforms that support long-term success. Drawing on extensive experience in both public and private market environments, Mr. Pursglove has been actively involved in capital raising, corporate development, strategic partnerships, and business optimization efforts. His entrepreneurial approach and forward-thinking leadership style have enabled him to drive innovation, improve operational performance, and position organizations for sustainable growth. He is particularly recognized for his ability to align strategic vision with disciplined execution, helping companies navigate evolving market dynamics while creating lasting stakeholder value. In addition to his executive leadership responsibilities, Mr. Pursglove serves on the Board of Directors of GridAI (Nasdaq: GRDX), where he contributes his expertise in corporate strategy, governance, capital markets, and growth initiatives. His combination of entrepreneurial insight, operational expertise, and transaction experience continues to make him a trusted advisor and leader across a broad spectrum of industries and business stages.

Stuart Porter

Director

Mr. Stuart Porter, Boston. Mr. Porter is the founder of Denham Capital Management LP, a leading energy and resources-focused global private equity firm with approximately $10 billion of assets under management across multiple fund vehicles. With nearly 30 years of senior investment experience, he serves as the firm’s Chief Executive Officer and Chief Investment Officer, as well as on the firm’s Investment Committee and Valuation Committee. Prior to founding Denham Capital, Mr. Porter was a founding partner of Sowood Capital Management LP and, prior thereto, was employed as a Vice President and Portfolio Manager at Harvard Management Company, Inc. where he focused on public and private transactions in the energy and commodities sectors. Mr. Porter began his career at the Chicago Board of Trade as an independent trader in the bond pit and post graduate school worked on the GSCI desk at J. Aron, the commodities division of Goldman Sachs. Mr. Porter received a Bachelor of Arts from the University of Michigan and a Master of Business Administration degree from the University of Chicago Booth School of Business.

Jason Sawyer

Director

Mr. Jason Sawyer is a 30-year veteran of the alternative investment industry and General Manager of Access Alternative Group S.A. (AAG), a Nassau-based venture investment and advisory firm. Based in Cancún, Mexico, he has led over $200 million in early and growth-stage investments across sectors including fintech, biotech, software, energy, and consumer products, partnering with leading family offices and institutions. Previously a Principal at Crane Capital (sold to Bear Stearns), he co-founded Candlebrook Capital and has raised over $3.5 billion for top-tier managers including Blackstone and Gottex. He has also co-founded and financed companies such as Caary Capital, Pacific West Stone, Sanna Health, and California Fitness, with successful exits and institutional backing. He currently leads finance and M&A for Quantum BioPharma (Nasdaq: QNTM) and serves on the board of The FUTR Corp (TSX.V: FTRC).

Lourdes Felix

Director

Mrs. Felix is a Hispanic entrepreneur and corporate finance executive with 30 years of experience in capital markets, public accounting, and the private sector. She is currently CEO, CFO, and Director of BioCorRx Inc., a leader in addiction treatment solutions, and co-founder and President of its subsidiary, BioCorRx Pharmaceuticals Inc. She has led multi-million-dollar financings, restructured and rebranded the company, and expanded its business model for long-term growth in addiction treatment and drug development. Lourdes has extensive expertise in finance, accounting, regulatory compliance (GAAP, SEC, SOX), and clinic operations management. She has successfully managed SEC filings, investor relations, and complex transactions with investment banks. Prior to BioCorRx, she worked in public accounting and the private sector, building deep experience in treasury, budgeting, and internal controls. Active in the Hispanic community and fluent in Spanish, Lourdes holds a B.S. in Accounting from the University of Phoenix and is an MBA candidate at Northeastern University’s D’Amore-McKim School of Business.

Guy Primus

Director

Guy Primus is a business and innovation leader with a 30-year track record of shaping strategy and driving growth in technology-driven organizations. He served as CEO and co-founder of The Virtual Reality Company and has led other tech-driven enterprises as CEO or COO. He previously held senior positions at Starbucks and Microsoft, is inventor on several technology patents, and chaired Georgia Tech’s School of Industrial and Systems Engineering Advisory Board, a program globally recognized for leadership in health systems.

Dr. Michael Holloway

Director

Dr. Michael Holloway is an Accomplished Emergency Medicine Physician and Medical Affairs executive. Extensive experience spanning diverse healthcare environments across British Columbia, Alberta and Ontario. Demonstrated leadership and medical innovation at VP level. . Proven track record in policy development, board governance and strategic consulting in healthcare and other fields. Complemented by a solid foundation in business administration and a commitment to volunteerism. Extensive exposure to early stage companies in multiple fields.